Clinical Trials Directory

Trials / Terminated

TerminatedNCT03211260

Effects of Proprioceptive Focal Stimulation (EQUISTASI) on Freezing of Gait in Parkinson's Disease

Effects of Proprioceptive Focal Stimulation (EQUISTASI) on Freezing of Gait in Parkinson's Disease: a Open, Single-arm Trial

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
ASST Gaetano Pini-CTO · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Freezing of gait (FOG) is a common disabling condition in Parkinson's disease (PD), causes falls, and impairs quality of life. Therapeutic options for this symptom are limited and of limited efficacy. Besides, the pathophysiology has been not clarified yet. Proprioceptive sensitivity is likely to play a role and recent studies have reported that high-frequency microfocal vibratory stimulation exert a modulatory effect of proprioceptive reflex circuits and could be considered a valuable treatment strategy. However, evidence is not available. The present study was designed to collect preliminary evidence of efficacy of a vibrotactile device (Equistasi) for the treatment of FOG.

Conditions

Interventions

TypeNameDescription
DEVICEEQUISTASIEquistasi is a nanotechnology for proprioceptive focal stimulation. Every patient will receive four patches to be placed on both legs for 4 weeks.

Timeline

Start date
2017-12-11
Primary completion
2019-07-19
Completion
2019-07-19
First posted
2017-07-07
Last updated
2019-09-12

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03211260. Inclusion in this directory is not an endorsement.